$1.21
0.054.31%
Pre-Market: 5:44 PM EDT
15 minutes delayed
Gain Therapeutics: Insider buying and selling updated today.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
At Gain Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have report no sales in the last 30 days, meanwhile, insiders have reported buying a total of 17.00K shares for a total value of $20.67K.
Jul 01, 2024 | Eric Richman | DIRECTOR | 17.00K | $1.22 | $20.67K | BUY | 5.91% | 304.46K | Jul 01 | View |
Apr 01, 2024 | Jeffrey Scott Riley | DIRECTOR | 30.00K | $3.86 | $115.77K | BUY | ∞ | 30.00K | Mar 28 | View |
Dec 22, 2023 | Matthias Alder | CHIEF EXECUTIVE OFFICER | 431.00 | $2.46 | -$506.76 | SELL-OPTIONS | 8.88% | 5.29K | Dec 20 - Dec 21 | View |
Dec 14, 2023 | Matthias Alder | CHIEF EXECUTIVE OFFICER | -1.82K | $2.50 | -$4.55K | SELL | -27.27% | 4.86K | Dec 07 | View |
May 27, 2022 | Eric I Richman | CHIEF EXECUTIVE OFFICER | 2.48K | $2.58 | $6.40K | BUY | 1.08% | 232.56K | May 25 | View |
May 23, 2022 | Eric I Richman | CHIEF EXECUTIVE OFFICER | 13.26K | $2.79 | $37.03K | BUY | 6.11% | 230.08K | May 19 - May 20 | View |
May 19, 2022 | Salvatore CAlabrese | CHIEF FINANCIAL OFFICER | 3.00K | $2.70 | $8.10K | BUY | ∞ | 0.00 | May 19 | View |
Browse insider trades on all stocks.